KR20090098610A - 입자크기가 조절된 술포데히드로아비에트산을 함유한쓴맛이 저감된 경구용 액상 조성물 - Google Patents
입자크기가 조절된 술포데히드로아비에트산을 함유한쓴맛이 저감된 경구용 액상 조성물 Download PDFInfo
- Publication number
- KR20090098610A KR20090098610A KR1020080024102A KR20080024102A KR20090098610A KR 20090098610 A KR20090098610 A KR 20090098610A KR 1020080024102 A KR1020080024102 A KR 1020080024102A KR 20080024102 A KR20080024102 A KR 20080024102A KR 20090098610 A KR20090098610 A KR 20090098610A
- Authority
- KR
- South Korea
- Prior art keywords
- liquid
- particle size
- bitter taste
- acid
- crospovidone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (5)
- 입자크기가 10 ~ 100㎛인 술포데히드로아비에트산 또는 그의 약학적으로 허용 가능한 염, 수화물, 용매화물을 포함하고 약제학적 허용되는 부형제를 함유하는 쓴맛이 저감된 소화성 위궤양, 위염 또는 염증성 장질환 치료용 경구용 액상 제제.
- 제 1 항에 있어서, 약제학적 부형제는 필수적으로 구연산나트륨, 크로스포비돈 및 액상 시클로덱스트린 혼합물을 함유하므로써 더욱 쓴맛이 저감된 소화성 위궤양, 위염 또는 염증성 장질환 치료용 경구용 액상 제제.
- 제 1 항 또는 제 2 항에 있어서, 술포데히드로아비에트산 1 중량부에 대하여 부형제 구연산나트륨, 크로스포비돈 및 액상 시클로덱스트린은 0.2:0.5~0.6:1 중량비로 함유되는 것을 특징으로 하는 액상 제제.
- 입자크기가 10 ~ 100㎛인 술포데히드로아비에트산 또는 그의 약학적으로 허용 가능한 염, 수화물, 용매화물을 포함하고 약제학적 부형제로 필수적으로 구연산나트륨, 크로스포비돈 및 액상 시클로덱스트린 혼합물을 함유하며, pH 5.0~5.5로 조절되어 안정화 된 액상 조성물을 갖는 쓴맛이 저감된 소화성 위궤양, 위염 또는 염증성 장질환 치료용 경구용 액상 제제.
- 술포데히드로아비에트산 또는 그의 약학적으로 허용 가능한 염, 수화물, 용매화물과, 필수적으로 부형제 구연산나트륨, 크로스포비돈 및 액상 시클로덱스트린 혼합물 을 함유하며 pH가 조절되어 쓴맛이 저감되고 안정화 된 소화성 위궤양, 위염 또는 염증성 장질환 치료용 경구용 액상 제제로서, 하기 (ⅰ)~(ⅲ)의 특징을 갖는 경구용 액상제제.(ⅰ) 술포데히드로아비에트산 또는 그의 약학적으로 허용 가능한 염, 수화물, 용매화물의 입자크기가 10 ~ 100㎛이며,(ⅱ) 부형제 구연산나트륨, 크로스포비돈 및 액상 시클로덱스트린 혼합물은 술포데히드로아비에트산 1 중량부에 대하여 구연산나트륨, 크로스포비돈 및 액상 시클로덱스트린 1:0.2:0.5~0.6:1 중량비로 함유하고,(ⅲ) pH가 5.0~5.5로 조절된 액상 제제.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080024102A KR100963051B1 (ko) | 2008-03-14 | 2008-03-14 | 입자크기가 조절된 술포데히드로아비에트산을 함유한쓴맛이 저감된 경구용 액상 조성물 |
JP2009057198A JP2009221199A (ja) | 2008-03-14 | 2009-03-10 | 粒子の大きさが調節されたスルホデヒドロアビエチン酸を含有した苦味が低減された経口用の液状組成物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080024102A KR100963051B1 (ko) | 2008-03-14 | 2008-03-14 | 입자크기가 조절된 술포데히드로아비에트산을 함유한쓴맛이 저감된 경구용 액상 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090098610A true KR20090098610A (ko) | 2009-09-17 |
KR100963051B1 KR100963051B1 (ko) | 2010-06-09 |
Family
ID=41238363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080024102A KR100963051B1 (ko) | 2008-03-14 | 2008-03-14 | 입자크기가 조절된 술포데히드로아비에트산을 함유한쓴맛이 저감된 경구용 액상 조성물 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2009221199A (ko) |
KR (1) | KR100963051B1 (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI577680B (zh) | 2008-10-22 | 2017-04-11 | 亞雷生物製藥股份有限公司 | 作為TRK激酶抑制劑之經取代吡唑并〔1,5-a〕嘧啶化合物 |
CN103772241B (zh) * | 2014-01-07 | 2015-08-26 | 珠海亿邦制药股份有限公司 | 一种磺化去氢松香酸盐的制备方法 |
JP7061602B2 (ja) | 2016-04-04 | 2022-04-28 | ロクソ オンコロジー, インコーポレイテッド | (S)-N-(5-((R)-2-(2,5-ジフルオロフェニル)-ピロリジン-1-イル)-ピラゾロ[1,5-a]ピリミジン-3-イル)-3-ヒドロキシピロリジン-1-カルボキサミドの液体製剤 |
US10045991B2 (en) | 2016-04-04 | 2018-08-14 | Loxo Oncology, Inc. | Methods of treating pediatric cancers |
DK3458456T3 (da) | 2016-05-18 | 2020-12-14 | Array Biopharma Inc | Fremstilling af (s)-n-(5-((r)-2-(2,5-difluorphenyl)pyrrolidin-1-yl)pyrazol[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidin-1-carboxamid |
JOP20190092A1 (ar) | 2016-10-26 | 2019-04-25 | Array Biopharma Inc | عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000178182A (ja) | 1998-12-17 | 2000-06-27 | Lion Corp | 崩壊性組成物 |
TW585762B (en) | 1999-11-11 | 2004-05-01 | Tanabe Seiyaku Co | Pharmaceutical composition for prophylaxis or treatment of inflammatory bowel diseases |
CN1596108A (zh) * | 2001-09-27 | 2005-03-16 | 田边制药株式会社 | Ecabet钠水溶液制剂 |
EP1582221A1 (en) * | 2004-03-31 | 2005-10-05 | Chiesi S.A. | Pharmaceutical oral compositions with a taste masking effect |
KR101011278B1 (ko) | 2005-07-22 | 2011-01-28 | 미쓰비시 타나베 파마 코퍼레이션 | 구강내 속붕괴성 정제 |
JP2008007420A (ja) * | 2006-06-27 | 2008-01-17 | Mitsubishi Tanabe Pharma Corp | 造粒物 |
JP2009067790A (ja) * | 2007-08-21 | 2009-04-02 | Nihon Generic Co Ltd | エカベトナトリウムの不快な味をマスキングしてなるゼリー状製剤 |
-
2008
- 2008-03-14 KR KR1020080024102A patent/KR100963051B1/ko active IP Right Grant
-
2009
- 2009-03-10 JP JP2009057198A patent/JP2009221199A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR100963051B1 (ko) | 2010-06-09 |
JP2009221199A (ja) | 2009-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5671560B2 (ja) | 固体投与形中のテトラサイクリン金属錯体 | |
AU2003220058B2 (en) | Palatable oral suspension and method | |
KR102024955B1 (ko) | 치환된 시클로부텐디온 항염 화합물의 콜린 염 | |
KR100963051B1 (ko) | 입자크기가 조절된 술포데히드로아비에트산을 함유한쓴맛이 저감된 경구용 액상 조성물 | |
RU2241460C2 (ru) | Фармацевтическая композиция цефуроксим аксетила с маскированным горьким вкусом | |
IL205352A (en) | Pharmaceutical preparations containing carbysmate aqueous preparations | |
JP2020502264A (ja) | 抗生物質組成物 | |
WO2006118137A1 (ja) | ビグアナイド系薬物を含有する粒状製剤 | |
WO2004066998A1 (ja) | 安定な経口用固形医薬組成物 | |
TW201713343A (zh) | 經口投與用醫藥組成物 | |
EP2320874A1 (en) | Solid pharmaceutical composition comprising exemestane | |
CN111989102A (zh) | 水性混悬液型药物制剂 | |
US20050063980A1 (en) | Gastric raft composition | |
PL202027B1 (pl) | Wodna farmaceutyczna kompozycja zawierająca związek chinolonowy | |
WO2024023785A1 (en) | A stable pharmaceutical oral liquid formulation of an antispasmodic agent | |
CN117858702A (zh) | 用于口服施用的美西律缓释组合物 | |
AU2017251803A1 (en) | Choline salt of an anti-inflammatory substituted cyclobutenedione compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121128 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20131127 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20141208 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20161123 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180104 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190103 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20200107 Year of fee payment: 11 |